Cite
HARVARD Citation
Tawfik, B. et al. (2021). Costs of treatment change following first-line somatostatin analog monotherapy among patients with neuroendocrine tumors. Journal of medical economics. pp. 1337-1345. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Tawfik, B. et al. (2021). Costs of treatment change following first-line somatostatin analog monotherapy among patients with neuroendocrine tumors. Journal of medical economics. pp. 1337-1345. [Online].